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1. Introduction 
H-glycylhistidyllysine-OH (GHL) is a tripeptide 
found at approximately 200 ng/ml in human plasma 
in association with the albumin and o-globulin frac- 
tions [ 1,2 J. When added to culture medium at 
1 S-100 ng/ml, synthetic GHL promotes the pro- 
liferation of hepatoma cells ]2,3], lymphocytes [4] 
and T-strain mycoplasma [5]; maintains the viability 
of normal hepatocytes [2,3], eosinophils [6], and 
macrophages [7]; inhibits the growth of glial cells [8]; 
and supports the growth and differentiation of neurons 
]8] and ascaris larvae [9]. At higher concentration, 
the tripeptide inhibits L929 cell growth (500 ng/ml) 
[lo] and maintains the viability of mast cells 
(20 pg/ml) during degranulation tests [ 1 I]. In general, 
GHL acts to reduce or eliminate the amount of serum 
required for culture of the various cell types or orga- 
nisms [2-4,6-9,111. Although the mechanism of
action of GHL is unknown, the tripeptide is co-iso- 
lated with copper and iron [ 12,131, and acts syner- 
gistically with these transition metals to stimulate the 
growth and metabolism of hepatoma cells maintained 
in grows-l~it~g amounts of serum [ 12,131. 
In this paper we describe the effects of 9 synthetic 
analogs of GHL on DNA synthesis in hepatoma cell 
culture. The results indicate that 2 structural features 
are involved in the bioactivities of GHL: (1) the histi- 
dyllysyl linkage and (2) a glycyl residue in either 
terminal position. 
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2, Materials and methods 
Synthetic peptides were obtained from the follow- 
ing suppliers: Gly-His-Lys from Fierce Chemical Co., 
Rickford, IL; Gly-His-(e-Gly-His)-Lys from 
Peninsula Laboratories, San Carlos, CA; Gly-His, Gly- 
Lys and His-Lys from Sigma Chemical Co., St. Louis, 
MO; His-Lys-Gly and His-Gly-Lys from Dr C. J. 
Lote, synthetized by methods detailed elsewhere [ 141; 
Gly-Lys-His, Gly-His-Orn, and Gly-His-Lys-His 
were prepared in our laboratory by solid phase synthesis 
131. 
The hepatoma cell line (HTC,) was obtained from 
the UCSF Cell Culture Facility; fetal calf serum, 
Swim’s S-77 medium, Eagle’s basal medium from 
GIBCO, Berkeley, CA; [methyZ-3H]thymidine, 
28 Ci/mM, from International Chemical and Nuclear, 
Irvine, CA; plastic 25 cm2 T-flasks from Falcon 
Plastics, Oxnard, CA. 
2.1. Purification of peptides 
All peptides were repurified by thin-layer silica gel 
chromatography, using as solvent CHCl3fMeOH/l7% 
NQOH : 2/2/l by volume, and eluted from the plate 
by methods previously published [2]. The peptide- 
containing solutions were passed through a Dowex 
50-X4 column (1 X 5 cm) at pH 7.0 in 0.1 M sodium 
phosphate. Double glass distilled water (10 column 
volumes) was passed through the column and peptide 
eluted with 5 ml 0.1 NaOH. The basic eluate was 
immediately neutralized with 1 N HCl, the solution 
lyophilized, then dissolved in 1 ml of 1% acetic acid. 
This solution was desalted on a Sephadex G-10 column 
(1 X 100 cm) eluted with 1% acetic acid, peptide 
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peaks located by absorbance at 210 nm, and lyo- 
philized. Peptides were converted from acetate salts 
to chloride salts by relyophilization in 0.02 N HCl. 
Final peptide concentration and composition were 
measured by amino acid analysis on a Beckman amino 
acid analyzer. 
2.2. Assay of peptide activities 
Changes in rates of DNA synthesis in a line of 
hepatoma cells (HTC4) [2] were used to estimate the 
bioactivity of purified peptides. Prior to assay, cellular 
growth rate was stabilized to baseline values by reduc- 
tion of the concentration of fetal calf serum in medium 
from 10 to 0.7% and subculture in spinner flasks for 
3 days. Under these conditions, the cells were quies- 
cent but viable. Cells were removed from medium by 
centrifugation (500 X g for 10 min), and lo6 cells 
plated in 25 cm’ T-flasks (Falcon 3012) in a medium 
consisting of 90.3% Eagle’s basal medium, 10% Swim’s 
S-77 medium, and 0.7% fetal calf serum. Peptides to 
be tested were added to concentrations of 2,20,200 
and 2000 ng/ml. 
Comparisons of peptide activities were made at 
48 hours of incubation, to minimize variability due 
to differences in initial response of cultures to pep- 
tides. Cells were pulsed with 0.5 PCi [3H]thymidine 
after 44 h in culture, and DNA synthesis was deter- 
mined following an additional 4 h of incubation, as 
previously described [ 21. 
3. Results 
The activity of analog peptides was compared to 
activity induced by GHL. Under the conditions 
employed, GHL was optimally active at 20-200 
ng/ml. GHL increased DNA synthesis 1 S-fold at 
2 ng/ml, 5 .l -fold at 20 ng/ml, 4.4-fold at 200 ng/ml 
and 1.9-fold at 2000 ng/ml. Among the 9 analogs, 
Gly-His-Lys-His, His-Lys-Gly and Gly-His-Orn 
displayed activities comparable with GHL (table 1). 
At the optimal concentration for GHL (20 ng/ml), 
Gly-Lys-His and His-Gly-Lys possessed 36% and 
13% of GHL activity respectively, while the activity 
of the pentapeptide Gly-His-(e-Gly-His)-Lys was 
intermediate at 20 ng/ml, and slightly more active at 
higher concentrations in comparison with Gly-Lys- 
His and His-Gly-Lys. There was no evidence of 
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2 20 200 2000 
Gly-His-Lys 50 408 339 91 
Gly-His-Lys-His 82 604 387 84 
His-Lys-Gly 31 368 353 56 
Gly-His-Orn 16 220 219 56 
Gly-Lys-His 2 36 65 31 
Gly-His-(e-Gly-His)-Lys 0 24 68 88 
His-Gly-Lys 2 13 81 29 
His-Lys 0 8 30 26 
Gly-His 0 0 6 3 
Gly-Lys 0 0 0 0 
Numbers represent % increase in [ “Hlthymidine incorpora- 
tion above control values. Average value for DNA synthesis 
in 12 control cultures without addition of synthetic peptide 
was 358 f 30 c.p.m. (k SD). Peptides are listed after Gly- 
His-Lys in order of activity at a concentration of 20 ng/ml. 
Within each experimental group, the standard deviation of 
sH-incorporation averaged 8% and did not exceed 17% of the 
mean 
inhibition at higher concentrations of this penta- 
peptide, possibly reflecting slow generation of GHL 
and Gly-His during incubation by proteolytic 
enzymes. Of the dipeptides, His-Lys had minimal 
activity equivalent to 3%of GHLactivity at 20 ng/ml, 
and 10% at 200 ng/ml. Gly-His and Gly-Lys were 
inactive. 
4. Discussion 
The results indicate that several synthetic analogs 
approach GHL in ability to stimulate DNA synthesis. 
Optimal activity appears to be associated with the 
histidyl-lysyl linkage, as indicated by the effects 
obtained with Gly-His-Lys-His, His-Lys-Gly, and 
GHL itself. Activity was decreased when lysine was 
replaced with ornithine, a closely related ammo acid. 
Deletion of the terminal glycine from GHL essentially 
eliminated activity. These findings suggest hat, in 
addition to the Hi-Lys sequence, glycine in either 
terminal position appears to be essential for expression 
of activity. The diversity of cell types and organisms 
which are responsive to GHL is consistent with a 
general metabolic function for the tripeptide. Recent 
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evidence suggests hat GHLmay mediate the transport 
of transition metals uch as copper. GHL functions 
syner~stic~ly with copper and iron to stimulate DNA 
synthesis and cell growth in hepatoma cultures [ 121, 
forms complexes with these metals in human plasma 
[ 131, and facilitates uptake of copper [I l] by hepa- 
toma cells maintained in growth-limiting amounts 
(0.7%) of serum ]1.5]. 
Among the side chains of ammo acids, the imidazole 
ring of histidine is the most effective chelator of tran- 
sition metals uch as copper and iron [16-l 81. Thus, 
the histidyl residue in GHL and its active analogs may 
be essential for chelation of these metals. Histidyl 
residues in peptides or proteins have a higher affinity 
for copper than free ~stid~e. Compared with histidine, 
both the dipeptide Gly-His and human albumin have 
considerably greater affinities for cupric ions [17-l 93. 
Accordingly, GHL would be expected to bind copper 
with an affinity comparable to that of human albu- 
min at its copper binding site, which contains ahistidyl 
residue at position 3 adjacent to a lysyl residue at 
position 4 [ 191. Since copper transport in human 
plasma occurs primarily through the albumin-bound 
copper fraction, GHL may play a role in the exchange 
of copper between plasma nd tissues. 
Evidence suggesting mediation of copper transport 
by low molecular weight compounds present in the 
circulation has been frequently reported [20-23 1. 
GHL is isolated in highest concentration from the 
albumin-rich fraction of plasma (Cohn Fraction V), 
where the tripeptide may form part of a ternary com- 
plex with albumin and copper, as does histidine [19]. 
It is possible, therefore, that a constituent of plasma 
with an affinity for transition metals may accept 
copper from the album&bound copper fraction in 
plasma, and may serve as a molecular weight carrier 
for transport of the metal from plasma to tissues. A
hypothetic~ transport pathway for copper based on 
these considerations and involving GHL, albumin and 
histidine is outlined in fig.1. 
The lysyl residue of GHLmay participate in charge- 
dependent interactions between the bioactive peptides 
and the cell surface. Thus, although the dipeptide 
Gly-His may chelate copper and iron nearly as effec- 
tively as GHL, chelation may not be accompanied by 
cellular binding in the absence of the lysyl residue 
with its basically charged e-amino group. Similarly, 
the higher activity of tripeptides with histidyl-lysyl 
PROPOSED MECHINISM OF GHL-MEDI4TED COPFW UPT4KE INTO CELLS 
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Fig. 1. The postulated mechanism of GHL-mediated transport 
of copper involves exchange of the metal between its binding 
sites on albumin, free histidine and GHL, with subsequent 
orientation of the GHL-copper complex on the cell surface 
in a conf~ration suitable for interaction with the plasma 
membrane. 
linkage compared with the dipeptide His-Lys, may 
reflect structural requirements of binding sites at the 
cell surface. 
~thou~ the biological effects of GHL have been 
demonstrated in diverse systems in vitro [l-l 11, 
among peptides tudied in this paper only GHL itself 
and a tripeptide with the tentative structure His-(Gly- 
Lys) have been isolated from biological sources. GHL 
has been extracted from plasma of several rn~rn~an 
species, including man [l]. His-(Gly-Lys) is a com- 
ponent of cat spinal cord, and both His-Gly-Lys 
and His-Lys-Gly have been reported to suppress 
the firing of neurons located in the spinal cord and 
medula oblongata of cats [ 141. These results imply 
that GHL and other o~gopeptides composed of 
histidine, lysine and glycine may exert a variety 
of tissue-specific regulatory functions. The ability 
of such peptides to chelate transition metals in 
human plasma, and the synergistic effects of GHL 
transition metal complexes in hepatoma cells [ 121 
suggest a potential role for these complexes in metab- 
olism of essential metal ions. Further studies of the 
biological properties of synthetic analogs of low 
molecular peptides found in vivo may clarify the 
mechanisms of action of these important and poorly 
understood modulatory factors. 
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